Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial

2015968 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet

Volume 387, Issue 10026, pp. 1405-1414

Field-Weighted Citation Impact: 57.50